234 related articles for article (PubMed ID: 7680387)
21. Reduced humoral immunity and atypical cell-mediated immunity in response to vaccination in cows naturally infected with bovine leukemia virus.
Frie MC; Sporer KR; Wallace JC; Maes RK; Sordillo LM; Bartlett PC; Coussens PM
Vet Immunol Immunopathol; 2016 Dec; 182():125-135. PubMed ID: 27863543
[TBL] [Abstract][Full Text] [Related]
22. Biochemical and immunological characterization of the bovine leukemia virus (BLV) envelope glycoprotein (gp51) produced in Saccharomyces cerevisiae.
Legrain M; Portetelle D; Dumont J; Burny A; Hilger F
Gene; 1989 Jul; 79(2):227-37. PubMed ID: 2551774
[TBL] [Abstract][Full Text] [Related]
23. Development and in vitro characterization of recombinant vaccinia viruses expressing bovine leukemia virus gp51 in combination with bovine IL4 or IL12.
Von Beust BR; Brown WC; Estes DM; Zarlenga DS; McElwain TF; Palmer GH
Vaccine; 1999 Jan; 17(4):384-95. PubMed ID: 9987178
[TBL] [Abstract][Full Text] [Related]
24. Peptide-based bovine leukemia virus (BLV) vaccine that induces BLV-Env specific Th-1 type immunity.
Ohishi K; Kabeya H; Amanuma H; Onuma M
Leukemia; 1997 Apr; 11 Suppl 3():223-6. PubMed ID: 9209348
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.
Bai L; Otsuki H; Sato H; Kohara J; Isogai E; Takeshima SN; Aida Y
Retrovirology; 2015 Dec; 12():106. PubMed ID: 26715158
[TBL] [Abstract][Full Text] [Related]
26. Pathogenicity of molecularly cloned bovine leukemia virus.
Rovnak J; Boyd AL; Casey JW; Gonda MA; Jensen WA; Cockerell GL
J Virol; 1993 Dec; 67(12):7096-105. PubMed ID: 8230433
[TBL] [Abstract][Full Text] [Related]
27. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant.
Earl PL; Moss B; Morrison RP; Wehrly K; Nishio J; Chesebro B
Science; 1986 Nov; 234(4777):728-31. PubMed ID: 3490689
[TBL] [Abstract][Full Text] [Related]
28. Protective effects of vaccination with bovine leukemia virus (BLV) Tax DNA against BLV infection in sheep.
Usui T; Konnai S; Tajima S; Watarai S; Aida Y; Ohashi K; Onuma M
J Vet Med Sci; 2003 Nov; 65(11):1201-5. PubMed ID: 14665749
[TBL] [Abstract][Full Text] [Related]
29. The bovine leukemia virus (BLV) envelope glycoprotein gp51 as a general model for the design of a subunit vaccine against retroviral infection: mapping of functional sites through immunological and structural data.
Callebaut I; Mornon JP; Burny A; Portetelle D
Leukemia; 1994 Apr; 8 Suppl 1():S218-21. PubMed ID: 7512181
[TBL] [Abstract][Full Text] [Related]
30. Vaccine-induced cytotoxic T lymphocytes protect against retroviral challenge.
Hislop AD; Good MF; Mateo L; Gardner J; Gatei MH; Daniel RC; Meyers BV; Lavin MF; Suhrbier A
Nat Med; 1998 Oct; 4(10):1193-6. PubMed ID: 9771756
[TBL] [Abstract][Full Text] [Related]
31. In vivo infection of sheep by bovine leukemia virus mutants.
Willems L; Kettmann R; Dequiedt F; Portetelle D; Vonèche V; Cornil I; Kerkhofs P; Burny A; Mammerickx M
J Virol; 1993 Jul; 67(7):4078-85. PubMed ID: 8389918
[TBL] [Abstract][Full Text] [Related]
32. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.
Stott EJ; Taylor G; Ball LA; Anderson K; Young KK; King AM; Wertz GW
J Virol; 1987 Dec; 61(12):3855-61. PubMed ID: 3316707
[TBL] [Abstract][Full Text] [Related]
33. Development of a specific serological test and an efficient subunit vaccine to control bovine leukemia virus infection.
Portetelle D; Burny A; Desmettre P; Mammerickx M; Paoletti E; Zavada J
Dev Biol Stand; 1990; 72():81-90. PubMed ID: 1704325
[TBL] [Abstract][Full Text] [Related]
34. Epitopes of bovine leukemia virus glycoprotein gp51 recognized by sera of infected cattle and sheep.
Bruck C; Portetelle D; Mammerickx M; Mathot S; Burny A
Leuk Res; 1984; 8(3):315-21. PubMed ID: 6205222
[TBL] [Abstract][Full Text] [Related]
35. Characterization of immune responses caused by bovine leukemia virus envelope peptides in sheep.
Kabeya H; Ohashi K; Sugimoto C; Onuma M
J Vet Med Sci; 1999 May; 61(5):475-80. PubMed ID: 10379937
[TBL] [Abstract][Full Text] [Related]
36. Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.
Portetelle D; Dandoy C; Burny A; Zavada J; Siakkou H; Gras-Masse H; Drobecq H; Tartar A
Virology; 1989 Mar; 169(1):34-41. PubMed ID: 2466371
[TBL] [Abstract][Full Text] [Related]
37. Protection against bovine leukosis virus infection in sheep with the BL 20 bovine lymphoblastoid cell line.
Roberts DH; Lucas MH; Sands J; Wibberley G
Vet Immunol Immunopathol; 1982 Nov; 3(6):635-42. PubMed ID: 6294966
[TBL] [Abstract][Full Text] [Related]
38. [Demonstration of the expression of bovine leukemogenic virus (BLV) in sheep lymphocytes by an immunofluorescence technic using monoclonal antibodies].
Djilali S; Parodi AL
Comp Immunol Microbiol Infect Dis; 1986; 9(4):317-23. PubMed ID: 3026722
[TBL] [Abstract][Full Text] [Related]
39. A human immunodeficiency virus type 1 Env-granulocyte-macrophage colony-stimulating factor fusion protein enhances the cellular immune response to Env in a vaccinia virus-based vaccine.
Rodr Guez D; Rodr Guez JR; Llorente M; V Zquez I; Lucas P; Esteban M; Mart Nez-A C; Del Real G
J Gen Virol; 1999 Jan; 80 ( Pt 1)():217-223. PubMed ID: 9934705
[TBL] [Abstract][Full Text] [Related]
40. A radioimmunoassay detecting the bovine leukaemia virus transmembrane protein gp30 and anti-gp30 antibodies in the serum of cattle.
Bossmann H; Siakkou H; Ulrich R; Uckert W; Kraft R; Rosenthal S; Rosenthal HA
Acta Virol; 1989 Mar; 33(2):113-20. PubMed ID: 2569806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
